Hydroxyprogesterone Caproate Injection Market

This product is light yellow or yellow sterilized oily liquid. Indications for this product can be used to treat habitual abortion, irregular menstruation, endometriosis, functional uterine bleeding, etc.

Hydroxyprogesterone Caproate Injection Market contains market size and forecasts of Hydroxyprogesterone Caproate Injection in global, including the following market information:

Global Hydroxyprogesterone Caproate Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hydroxyprogesterone Caproate Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hydroxyprogesterone Caproate Injection companies in 2021 (%)

The global Hydroxyprogesterone Caproate Injection market was valued at 270.6 million in 2021 and is projected to reach US$ 299 million by 2028, at a CAGR of 1.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

250mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hydroxyprogesterone Caproate Injection include AMAG, Prasco, American Regent, AuroMedics, Mylan, Slayback Pharma, Zydus, PRM Life Science and ANI Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hydroxyprogesterone Caproate Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hydroxyprogesterone Caproate Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydroxyprogesterone Caproate Injection Market Segment Percentages, by Type, 2021 (%)

• 250mg/ml
• 275mg/1.1ml

Global Hydroxyprogesterone Caproate Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydroxyprogesterone Caproate Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Hydroxyprogesterone Caproate Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hydroxyprogesterone Caproate Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hydroxyprogesterone Caproate Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Hydroxyprogesterone Caproate Injection revenues share in global market, 2021 (%)
• Key companies Hydroxyprogesterone Caproate Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Hydroxyprogesterone Caproate Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AMAG
• Prasco
• American Regent
• AuroMedics
• Mylan
• Slayback Pharma
• Zydus
• PRM Life Science
• ANI Pharmaceuticals
• SG pharm